Hyperoxaluric calcium nephrolithiasis

Endocrinology and Metabolism Clinics of North America

Volumn 31, Issue 4, 2002, Pages 927-949

  Asplin, John R ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; CALCIUM OXALATE; PYRIDOXINE;

CLINICAL EXAMINATION; CLINICAL FEATURE; DIETARY INTAKE; DISEASE SEVERITY; GENETIC DISORDER; HUMAN; HYPEROXALURIA; KIDNEY FUNCTION; KIDNEY METABOLISM; NEPHROLITHIASIS; OXALOSIS; PRIORITY JOURNAL; REVIEW; SOLUBILITY; ADOLESCENT; CALCIUM INTAKE; CHILD; DRINKING; INTESTINE ABSORPTION; METABOLISM; OXALOSIS 1; PROTEIN INTAKE; STONE FORMATION; URINE;

ADOLESCENT; CALCIUM OXALATE; CALCIUM, DIETARY; CHILD; DIETARY PROTEINS; DRINKING; HUMANS; HYPEROXALURIA, PRIMARY; INTESTINAL ABSORPTION; KIDNEY CALCULI; LITHIASIS; PYRIDOXINE;

EID: 0036896977     PISSN: 08898529     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8529(02)00030-0     Document Type: Review

References (116)

1. Robertson WG, Peacock M. The cause of idiopathic calcium stone disease: Hypercalciuria or hyperoxaluria? Nephron 1980;26:105-10.
2. Curhan GC, Willett WC, Speizer FE, et al. Twenty-four-hour urine chemistries and the risk of kidney stones among women and men, Kidney Int 2001;59:2290-8.
3. Hodgkinson A. Relationships between oxlic acid, calcium, magnesium and creatinine excretion in normal men and male patients with calcium oxalate kidney stones. Clin Sci Mol Med 1974;46:357-67.
4. Larsson L, Tiselius HG. Hyperoxaluria. Mineral Electrolyte Metab 1987;13:242-50.
5. Baggio B, Gambaro G, Favaro S, et al. Prevalence of hyperoxaluria in idiopathic calcium oxalate kidney stone disease. Nephron 1983;35:11-4.
6. Laminski NA, Meyers AM, Kruger M, et al. Hyperoxaluria in patients with recurrent calcium oxalate calculi: Dietary and other risk factors. Br J Urol 1991;68:454-8.
7. Levy FL, Adams-Huet B, Pak CY. Ambulatory evaluation of nephrolithiasis: An update of a 1980 protocol. Am J Med 1995;98:50-9.
8. Zarembski PM, Hodgkinson A. The oxalic acid content of English diets. Br J Nutr 1962;16:672-81.
9. Hesse A, Schneeberger W, Engfeld S, et al. Intestinal hyperabsorption of oxalate in calcium oxalate stone formers: Application of a new test with [13C2] oxalate. J Am Soc Nephrol 1999;10(Suppl 14):S329-33.
10. Lindsjo M, Danielson BG, Fellstrom B, et al. Intestinal oxalate and calcium absorption in recurrent renal stone formers and healthy subjects. Scand J Urol Nephrol 1989;23:55-9.
11. Marangella M, Fruttero B, Bruno M, et al. Hyperoxaluria in idiopathic calcium stone disease: Further evidence of intestinal hyperabsorption of oxalate. Clin Sci (Lond) 1982;63:381-5.
12. Tiselius HG, Ahlstrand C, Lundstrom B, et al. [14C] Oxalate absorption by normal persons, calcium oxalate stone formers, and patients with surgically disturbed intestinal function. Clin Chem 1981;27:1682-5.
13. Holmes RP, Goodman HO, Assimos DG. Dietary oxalate and its intestinal absorption. Scanning Microsc 1995;9:1109-18.
14. Hatch M, Freel RW, Vaziri ND. Intestinal excretion of oxalate in chronic renal failure. J Am Soc Nephrol 1994;5:1339-43.
15. Brinkley L, McGuire J, Gregory J, et al. Bioavailability of oxalate in foods. Urology 1981;17:534-8.
16. Brinkley LJ, Gregory J, Pak CYC. A further study of oxalate bioavailability in foods. J Urol 1990;144:94-6.
17. Allison MJ, Cook HM. Oxalate degradation by microbes of the large bowel of herbivores: The effect of dietary oxalate. Science 1981;212:6756.
18. Allison MJ, Dawson KA, Mayberry WR, et al. Oxalobacter formigenes gen. nov., sp. nov.: Oxalate-degrading anaerobes that inhabit the gastrointestinal tract. Arch Microbiol 1985;141:1-7.
19. Sidhu H, Holmes RP, Allison MJ, et al. Direct quantification of the enteric bacterium Oxalobacter formigenes in human fecal samples by quantitative competitive-template PCR. J Clin Microbiol 1999;37:1503-9.
20. Troxel SA, Low RK, Sidhu H. Intestinal oxalobacter formigenes colonization and urinary oxalate levels in calcium oxalate stone formers. J Urol 2001;165:245.
21. Sidhu H, Allison MJ, Chow JM, et al. Rapid reversal of hyperoxaluria in a rat model after probiotic administration of Oxalobacter formigenes. J Urol 2001;166:1487-91.
22. Campieri C, Campieri M, Bertuzzi V, et al. Reduction of oxaluria after an oral course of lactic acid bacteria at high concentration. Kidney Int 2001;60:1097-105.
23. Holmes RP, Assimos DG. Glyoxylate synthesis, and its modulation and influence on oxalate synthesis. J Urol 1998;160:1617-24.
24. Baker EM, Saari JC, Tolbert BM. Ascorbic acid metabolism in man. Am J Clin Nutr 1966;19:371-8.
25. Nguyen NU, Dumoulin G, Henriet MT, et al. Increase in urinary calcium and oxalate after fructose infusion. Horm Metab Res 1995:27:155-8.
26. Conyers RA, Bais R, Role AM. The relation of clinical catastrophes, endogenous oxalate production, and urolithiasis. Clin Chem 1990;36:1717-30.
27. Nguyen NU, Dumoulin G, Henriet MT, et al. Carbohydrate metabolism and urinary excretion of calcium and oxalate after ingestion of polyol sweeteners. J Clin Endocrinol Metab 1993;77:388-92.
28. Bushinsky DA, Asplin JR, Grynpas MD, et al. Calcium oxalate stone formation in genetic hypercalciuric stone-forming rats. Kidney Int 2002;61:975-87.
29. Cook DA, Henderson LM. The formation of oxalic acid from the side chain of aromatic amino acids. Biochim Biophys Acta 1969;184:404-9.
30. Gambardella RL, Richardson KE. The pathways of oxalate formation from phenylalanine, tyrosine, tryptophan and ascorbic acid in the rat. Biochim Biophys Acta 1977;499:156-68.
31. Hoppe B, Kemper MJ, Bokenkamp A, et al. Plasma calcium-oxalate saturation in children with renal insufficiency and in children with primary hyperoxaluria. Kidney Int 1998;54:921-5.
32. Weinman EJ, Frankfurt SJ, Ince A, et al. Renal tubular transport of organic acids. J Clin Invest 1978;61:801-6.
33. Aronson PS, Giebisch G. Mechanisms of chloride transport in the proximal tubule. Am J Physiol 1997;273:F179-92.
34. Osswald H, Hautmann R. Renal elimination kinetics and plasma half-life of oxalate in man. Urol Int 1979;34:440-50.
35. Williams HE, Johnson GA, Smith Jr LH. The renal clearance of oxalate in normal subjects and patients with primary hyperoxaluria. Clin Sci 1971;41:213-8.
36. Kasidas GP, Nemat S, Rose GA. Plasma oxalate and creatinine and oxalate/creatinine clearance ratios in normal subjects and in primary hyperoxaluria. Clin Chim Acta 1990;191:67-77.
37. Lindsjo M, Fellstrom B, Danielson BG, et al. Hyperoxaluria or hypercalciuria in nephrolithiasis: The importance of renal tubular functions. Eur J Clin Invest 1990;20:546-54.
38. Chandhoke PS, Fan J. Transport of oxalate across the rabbit papillary surface epithelium. J Urol 2002;164:1724-8.
39. Danpure CJ. Primary hyperoxaluria. In: Scriver CR, Beaudet AL, Sly WS, et al, editors. The Metabolic and Molecular Bases of Inherited Disease. 8th Edition. New York: McGraw-Hill; 2001. p. 3323-67.
40. Purdue PE, Lumb MJ, Fox M, et al. Characterization and chromosomal mapping of a genomic clone encoding human alanine:glyoxylate aminotransferase. Genomics 1991;10:34-42.
41. Lumb MJ, Drake AF, Danpure CJ. Effect of N-terminal alpha-helix formation on the dimerization and intracellular targeting of alanine:glyoxylate aminotransferase. J Biol Chem 1999;274:20587-96.
42. Danpure CJ. The molecular basis of alanine:glyoxylate aminotransferase mistargeting: The most common single cause of primary hyperoxaluria type 1. J Nephrol 1998;11(Suppl 1):8-12.
43. Purdue PE, Takada Y, Danpure CJ. Identification of mutations associated with peroxisome-to-mitochondrion mistargeting of alanine/glyoxylate aminotransferase in primary hyperoxaluria type 1. J Cell Biol 1990;111:2341-51.
44. Danpure CJ, Purdue PE, Fryer P, et al. Enzymological and mutational analysis of a complex primary hyperoxaluria type 1 phenotype involving alanine:glyoxylate amino-transferase peroxisome-to-mitochondrion mistargeting and intraperoxisomal aggregation. Am J Hum Genet 1993;53:417-32.
45. Williams HE, Smith LH. L-glyceric aciduria:a new genetic variant of primary hyperoxaluria. N Engl J Med 1968;278:233-9.
46. Cramer SD, Ferree PM, Lin K, et al. The gene encoding hydroxypyruvate reductase (GRHPR) is mutated in patients with primary hyperoxaluria type II. Hum Mol Genet 1999;8:2063-9.
47. Rumsby G, Cregeen DP. Identification and expression of a cDNA for human hydroxypyruvate/glyoxylate reductase. Biochim Biophys Acta 1999;1446:383-8.
48. Hockaday TDR, Clayton JE, Frederick EW, et al. Primary hyperoxaluria. Medicine (Baltimore) 1964;43:315-45.
49. Leumann EP. Primary hyperoxaluria: An important cause of renal failure in infancy. Int J Pediatr Nephrol 1985;6:13-6.
50. Hoppe B, Danpure CJ, Rumsby G, et al. A vertical (pseudodominant) pattern of inheritance in the autosomal recessive disease primary hyperoxaluria type 1: Lack of relationship between genotype, enzymic phenotype, and disease severity. Am J Kidney Dis 1997;29:36-44.
51. Tarn AC, von Schnakenburg C, Rumsby G. Primary hyperoxaluria type 1: Diagnostic relevance of mutations and polymorphisms in the alanine:glyoxylate aminotransferase gene (AGXT). J Inherit Metab Dis 1997;20:689-96.
52. Latta K, Brodehl J. Primary hyperoxaluria type I. Eur J Pediatr 1990;149:518-22.
53. Kopp N, Leumann E. Changing pattern of primary hyperoxaluria in Switzerland. Nephrol Dial Transplant 1995;10:2224-7.
54. Milliner DS, Eickholt JT, Bergstralh EJ, et al. Results of long-term treatment with orthophosphate and pyridoxine in patients with primary hyperoxaluria. N Engl J Med 1994;331:1553-8.
55. Chlebeck PT, Milliner DS, Smith LH. Long-term prognosis in primary hyperoxaluria type II (L-glyceric aciduria). Am J Kidney Dis 1994;23:255-9.
56. Milliner DS, Wilson DM, Smith LH. Phenotypic expression of primary hyperoxaluria: Comparative features of types I and II. Kidney Int 2001;59:31-6.
57. Mansell MA. Primary hyperoxaluria type 2. Nephrol Dial Transplant 1995;10(Suppl 8):58-60.
58. Hoppe B, Jahnen A, Bach D, et al. Urinary calcium oxalate saturation in healthy infants and children. J Urol 1999;158:557-9.
59. Rumsby G, Sharma A, Cregeen DP, et al. Primary hyperoxaluria type 2 without Lglyceriaciduria: Is the disease under-diagnosed? Nephrol Dial Transplant 2001;16:1697-9.
60. Van Acker KJ, Eyskens FJ, Espeel MF, et al. Hyperoxaluria with hyperglycoluria not due to alanine:glyoxylate aminotransferase defect: A novel type of primary hyperoxaluria. Kidney Int 1996;50:1747-52.
61. Saborio P, Scheinman JI. Transplantation for primary hyperoxaluria in the United States. Kidney Int 1999;56:1094-100.
62. Marangella M, Petrarulo M, Bianco O, et al. Glycolate determination detects type I primary hyperoxaluria in dialysis patients. Kidney Int 1991;39:149-54.
63. Rumsby G. Experience in prenatal diagnosis of primary hyperoxaluria type 1. J Nephrol 1998;11(Suppl 1):13-4.
64. Yendt ER, Cohanim M. Response to a physiologic dose of pyridoxine in type 1 primary hyperoxaluria. N Engl J Med 1985;312:953-7.
65. Van Den Berg CJ, Kumar R, Wilson DM, et al. Orthophosphate therapy decreases urinary calcium excretion and serum 1,25-dihydroxyvitamin D concentrations in idiopathic hypercalciuria. J Clin Endocrinol Metab 1980;51:998-1001.
66. Breslau NA, Padalino P, Kok D, et al. Physicochemical effects of a new slow release potassium phosphate preparation in absorptive hypercalciuria. J Bone Miner Res 1995;10:394-400.
67. Leumann E, Hoppe B, Neuhaus T. Management of primary hyperoxaluria: Efficacy of oral citrate administration. Pediatr Nephrol 1993;7:207-11.
68. Silver L, Brendler H. Use of magnesium oxide in management of familial hyperoxaluria. J Urol 1971;106:274-8.
69. Jamieson NV. The results of combined liver/kidney transplantation for primary hyperoxaluria 1984-1997. The European PH1 transplant registry report. J Nephrol 1998;11(Suppl 1):36-41.
70. Broyer M, Brunner FP, Brynger H, et al. Kidney transplantation in primary oxalosis: Data from the EDTA Registry. Nephrol Dial Transplant 1990;5:332-6.
71. Allen AR, Thompson EM, Williams G, et al. Selective renal transplantation in primary hyperoxaluria type 1. Am J Kidney Dis 1996;27:891-5.
72. Marangella M. Transplantation strategies in type 1 primary hyperoxaluria: The issue of pyridoxine responsiveness. Nephrol Dial Transplant 1999;14:301-3.
73. Cochat P, Scharer K. Should liver transplantation be performed before advanced renal insufficiency in primary hyperoxaluria type 17 Pediatr Nephrol 1993;7:212-8.
74. Cochat P, Gaulier JM, Koch Nogueira PC, et al. Combined liver-kidney transplantation in primary hyperoxaluria type 1. Eur J Pediatr 1999;158(Suppl 2):S75-80.
75. Chadwick VS, Modha K, Dowling RH. Mechanism for hyperoxaluria in patients with ileal dysfunction. N Engl J Med 1973;289:172-6.
76. Dobbins JW, Binder HJ. Effect of bile salts and fatty acids on the colonic absoprtion of oxalate. Gastroenterology 1976;70:1096-100.
77. Dobbins JW, Binder HJ. Importance of the colon in enteric hyperoxaluria. N Engl J Med 1977;296:298-301.
78. Allison MJ, Cook HM, Milne DB, et al. Oxalate degradation by gastrointestinal bacteria from humans. J Nutr 1986;116:455-60.
79. Mole DR, Tomson CR, Mortensen N, et al. Renal complications of jejuno-ileal bypass for obesity. Q J Med 2001;94:69-77.
80. Stauffer JQ. Hyperoxaluria and intestinal disease. The role of steatorrhea and dietary calcium in regulating intestinal oxalate absorption. Am J Dig Dis 1977;22:921-8.
81. Stauffer JQ, Humphreys MH, Weir GJ. Acquired hyperoxaluria with regional enteritis after ileal resection. Role of dietary oxalate. Ann Intern Med 1973;79:383-91.
82. Hess B, Jost C, Zipperle L, et al. High-calcium intake abolishes hyperoxaluria and reduces urinary crystallization during a 20-fold normal oxalate load in humans. Nephrol Dial Transplant 1998;13:2241-7.
83. Holmes RP, Goodman HO, Assimos DG. Contribution of dietary oxalate to urinary oxalate excretion. Kidney Int 2001;59:270-6.
84. Curhan GC, Willett WC, Rimm EB, et al. A prospective study of dietary calcium and other nutrients and the risk of symptomatic kidney stones. N Engl J Med 1993;328:833-8.
85. Curhan GC, Willett WC, Speizer FE, et al. Comparison of dietary calcium with supplemental calcium and other nutrients as factors affecting the risk for kidney stones in women. Ann Intern Med 1997;126:497-504.
86. Lemann Jr J, Pleuss JA, Worcester EM, et al. Urinary oxalate excretion increases with body size and decreases with increasing dietary calcium intake among healthy adults. Kidney Int 1996;49:200-8.
87. Colussi G, Antonacci A, Surian M, et al. Effects of low calcium diet on urinary calcium and oxalate excretion in patients with idiopathic calcium nephrolithiasis. Contrib Nephrol 1984;37:22-6.
88. Galosy R, Clarke L, Ward DL, et al. Renal oxalate excretion in calcium urolithiasis. J Urol 1980;123:320-3.
89. Jaeger P, Portmann L, Jacquet AF, et al. Influence of the calcium content of the diet on the incidence of mild hyperoxaluria in idiopathic renal stone formers. Am J Nephrol 1985;5:40-4.
90. Marshall RW, Cochran M, Hodgkinson A. Relationships between calcium and oxalic acid intake in the diet and their excretion in the urine of normal and renal-stone forming subjects. Clin Sci 1972;43:91-9.
91. Massey LK, Sutton RA. Modification of dietary oxalate and calcium reduces urinary oxalate in hyperoxaluric patients with kidney stones. J Am Diet Assoc 1993;93:1305-7.
92. Messa P, Marangella M, Paganin L, et al. Different dietary calcium intake and relative supersaturation of calcium oxalate in the urine of patients forming renal stones. Clin Sci (Lond) 1997;93:257-63.
93. Pak CY, Peterson R, Poindexter JR. Adequacy of a single stone risk analysis in the medical evaluation of urolithiasis. J Urol 2001;165:378-81.
94. Robertson WG, Peacock M. The pattern of urinary stone disease in Leeds and in the United Kingdom in relation to animal protein intake during the period 1960-1980. Urol Int 1982;37:394-9.
95. Robertson WG, Peacock M, Hodgkinson A. Dietary changes and the incidence of urinary calculi in the U.K. between 1958 and 1976. J Chron Dis 1979;32:469-76.
96. Robertson WG, Heyburn PJ, Peacock M, et al. The effect of high animal protein intake on the risk of calcium stone-formation in the urinary tract. Clin Sci 1979;57:285-8.
97. Coe FL. Hyperuricosuric calcium oxalate nephrolithiasis. Adv Exp Med Biol 1980;128:439-50.
98. Breslau NA, Brinkley L, Hill KD, et al. Relationship of animal protein-rich diet to kidney stone formation and calcium metabolism. J Clin Endocrinol Metab 1988;66:140-6.
99. Butz M, Hoffmann H, Kohlbecker G. Dietary influence on serum and urinary oxalate in healthy subjects and oxalate stone formers. Urol Int 1980;35:309-15.
100. Fellstrom B, Danielson BG, Karlstrom B, et al. Effects of high intake of dietary animal protein on mineral metabolism and urinary supersaturation of calcium oxalate in renal stone formers. Br J Urol 1984;56:263-9.
101. Giannini S, Nobile M, Sartori L, et al. Acute effects of moderate dietary protein restriction in patients with idiopathic hypercalciuria and calcium nephrolithiasis. Am J Clin Nutr 1999;69:267-71.
102. Holmes R, Goodman H, Hart L, et al. Relationship of protein intake to urinary oxalate and glycolate excretion. Kidney Int 1993;44:366-72.
103. Marangella M, Bianco O, Martini C, et al. Effect of animal and vegetable protein intake on oxalate excretion in idiopathic calcium stone disease. Br J Urol 1989;63:348-51.
104. Nguyen QV, Kalin A, Drouve U, et al. Sensitivity to meat protein intake and hyperoxaluria in idiopathic calcium stone formers. Kidney Int 2001;59:2273-81.
105. Urivetzky M, Braverman S, Motola JA, et al. Absence of effect of allopurinol on oxalate excretion by stone patients on random and controlled diets. J Urol 1990;144:97-8.
106. Kaelin A, Nguyen QV, Casez JP, Jaeger P. Deficient vitamin B-6 metabolism and hypersensitivity to dietary protein inidopathic calcium stone formers. In: Rodgers, A. L, Hibbert, B. E., Hess, B., Khan, S. R., and Preminger, G. M., editors. Urolithiasis [Ref Type: Serial Book, Monograph] Capetown: University of Capetown, 2000. p. 458-60.
107. Borghi L, Schianchi T, Meschi T, et al. Comparison of two diets for the prevention of recurrent stones in idiopathic hypercalciuria. N Engl J Med 2002;346:77-84.
108. Auer BL, Auer D, Rodgers AL. The effect of ascorbic acid injestion on the biochemical and physical chemical risk factors associated with calcium oxalate kidney stone formation. Clin Chem Lab Med 1998;36:143-8.
109. Hatch M, Mulgrew S, Bourke E, et al. Effect of megadoses of ascorbic acid on serum and urinary oxalate. Eur Urol 1980;6:166-9.
110. Urivetzky M, Kessaris D, Smith AD. Ascorbic acid overdosing: A risk factor for calcium oxalate nephrolithiasis. J Urol 1992;147:1215-8.
111. Lemann Jr J, Hornick LJ, Pleuss JA, et al. Oxalate is overestimated in alkaline urines collected during administration of bicarbonate with no specimen pH adjustment. Clin Chem 1989;35:2107-10.
112. Auer BL, Auer D, Rodgers AL. Relative hyperoxaluria, crystalluria and haematuria after megadose ingestion of vitamin C. Eur J Clin Invest 1998;28:695-700.
113. Mashour S, Turner Jr JF, Merrell R. Acute renal failure, oxalosis, and vitamin C supplementation: A case report and review of the literature. Chest 2000;118:561-3.
114. Curhan GC, Willett WC, Rimm EB, et al. A prospective study of the intake of vitamins C and B6, and the risk of kidney stones in men, J Urol 1996;155:1847-51
115. Curhan GC, Willett WC, Speizer FE, et al. Intake of vitamins B6 and C and the risk of kidney stones in women. J Am Soc Nephrol 1999;10:840-5.
116. Massey LK, Palmer RG, Horner HT. Oxalate content of soybean seeds (Glycine max: Leguminosae), soyfoods, and other edible legumes. J Agric Food Chem 2001;49:4262-6.